Coronary Stents Market Research Report from 2023 forecast to 2029, by Manufacturers, Regions, Type and Application

The global Coronary Stents market size was valued at USD 6615.2 million in 2022 and is forecast to a readjusted size of USD 8549.5 million by 2029 with a CAGR of 3.7% during review period.

Coronary stent is a tube-shaped device placed in the coronary arteries that supply blood to the heart, to keep the arteries open in the treatment of coronary heart disease.

North America is the largest producer, with a market share nearly 70%. Abbott Vascular, Medtronic and Boston Scientific are the top 3 players of Coronary Stents market, and they had a nearly 70% combined market share.

This report is a detailed and comprehensive analysis for global Coronary Stents market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Coronary Stents market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Coronary Stents market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Coronary Stents market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Coronary Stents market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Coronary Stents
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace

This report profiles key players in the global Coronary Stents market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

   Medtronic
   Boston Scientific
   Biosensors
   Terumo
   MicroPort
   Lepu Medical
   B.Braun
   Atrium Medical
   SINOMED
   LBC
   Essen Technology

   Bare-metal Stent (BMS)
   Drug-eluting Stent (DES)
   Bioresorbable Vascular Scaffold (BVS)

   ASCs
   Hospitals
   Cardiology Center

   North America (United States, Canada and Mexico)
   Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
   Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
   South America (Brazil, Argentina, Colombia, and Rest of South America)
   Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

What are the strengths of the coronary stents market in 2025?

The coronary stents market in 2025 benefits from advanced technological innovations, such as drug-eluting stents that reduce restenosis rates. Increased awareness about cardiovascular diseases and a growing aging population also contribute to market expansion. Additionally, the rise of minimally invasive procedures is boosting the demand for stents in interventional cardiology.

What are the weaknesses of the coronary stents market in 2025?

The high cost of coronary stents and related procedures may limit accessibility for certain demographics, particularly in developing countries. There's also the risk of complications such as stent thrombosis, which could affect market adoption. Furthermore, the market is highly dependent on healthcare policies and reimbursement rates, which may vary by region.

What opportunities exist for the coronary stents market in 2025?

The global increase in the incidence of cardiovascular diseases presents an ongoing opportunity for market growth. Additionally, the development of bioresorbable stents and improvements in drug delivery technologies create new avenues for innovation. Expansion into emerging markets with rising healthcare infrastructure and growing middle-class populations also offers growth potential.

What threats does the coronary stents market face in 2025?

One significant threat is the growing competition from alternative treatments, such as bypass surgery or emerging drug therapies, which may reduce the demand for stents. Regulatory challenges and the potential for stringent regulations on medical devices could also hinder market growth. Economic downturns and shifts in healthcare funding may impact the purchasing power of both patients and healthcare providers.

How do political factors impact the coronary stents market in 2025?

Political factors, such as government policies on healthcare funding and medical device regulation, directly influence the coronary stents market. Countries with strong healthcare systems and favorable reimbursement policies will likely see a higher adoption of stents. However, political instability and changing healthcare regulations in certain regions may pose challenges to market growth.

How do economic factors affect the coronary stents market in 2025?

Economic conditions play a crucial role in shaping the coronary stents market. During economic downturns, healthcare budgets may shrink, leading to reduced spending on medical devices like stents. On the other hand, economic growth in emerging markets could increase access to healthcare and drive demand for coronary stents as more people seek treatment for cardiovascular diseases.

How do social factors influence the coronary stents market in 2025?

Social factors such as an aging population and changing lifestyles (e.g., poor diet and lack of exercise) contribute to a rise in cardiovascular diseases, driving the demand for coronary stents. Public health initiatives and awareness campaigns also promote early detection and intervention, which further supports the market. However, social disparities in healthcare access can limit the reach of stent therapies in lower-income populations.

How do technological factors impact the coronary stents market in 2025?

Advancements in stent technology, such as the development of drug-eluting and bioresorbable stents, significantly enhance patient outcomes and reduce complications. New materials and improved delivery systems are also driving innovation. These technological advancements are expected to expand the market by improving patient recovery times and long-term success rates.

How do environmental factors affect the coronary stents market in 2025?

Environmental factors, including sustainability concerns and regulations regarding medical device disposal, may influence manufacturing practices in the coronary stents market. The growing focus on eco-friendly materials and processes could lead to new innovations in stent production. However, the environmental impact of healthcare waste management, particularly for disposable stent components, could become a regulatory challenge.

How do legal factors shape the coronary stents market in 2025?

Legal factors, such as strict regulatory approval processes for new medical devices, can impact the speed at which new stent technologies enter the market. Additionally, patent laws affect innovation, with companies relying on intellectual property protections to safeguard new product developments. Legal liabilities related to device safety, such as lawsuits or recalls, can also affect market dynamics.

Who are the suppliers in the coronary stents market in 2025?

Suppliers include manufacturers of stent components such as metals (stainless steel, cobalt-chromium), polymers, and drug-eluting materials. Additionally, suppliers of medical device technologies, equipment for stent implantation, and raw materials like biodegradable substances are critical in the production process.

Who are the inputs involved in the coronary stents market in 2025?

Inputs include advanced materials like biocompatible metals and polymers, drug coatings for drug-eluting stents, cutting-edge manufacturing technologies, and skilled labor. Research and development (R&D) investments are also essential inputs for innovation and regulatory approvals.

What are the processes in the coronary stents market in 2025?

Key processes in the coronary stents market include the design and development of stents, clinical trials for safety and efficacy, manufacturing, quality control, and distribution. The implantation procedure involves interventional cardiologists using these stents during percutaneous coronary interventions (PCI), along with post-implantation monitoring and care.

Who are the customers in the coronary stents market in 2025?

Customers include hospitals, cardiac clinics, and healthcare providers who purchase coronary stents for patient use. Additionally, patients suffering from cardiovascular diseases, including coronary artery disease (CAD), are direct beneficiaries of these products. Healthcare insurance companies also play a role in supporting patient access through reimbursement.

What are the outputs in the coronary stents market in 2025?

Outputs include coronary stents such as bare-metal stents, drug-eluting stents, and bioresorbable stents. Other outputs include post-implantation patient care products, clinical data on stent performance, and overall improved cardiovascular health outcomes for patients.

What is the threat of new entrants in the coronary stents market in 2025?

The threat of new entrants is moderate due to the high barriers to entry, such as the need for significant investment in R&D, manufacturing capabilities, and regulatory approvals. However, technological advancements and the potential for niche innovations could attract new players, particularly in emerging markets.

What is the bargaining power of suppliers in the coronary stents market in 2025?

The bargaining power of suppliers is moderate. While there are a limited number of specialized suppliers for materials like biocompatible metals and drug coatings, the large number of suppliers for generic materials reduces their overall power. Manufacturers can also leverage multiple sources for certain components.

What is the bargaining power of buyers in the coronary stents market in 2025?

The bargaining power of buyers is moderate to high. Hospitals and healthcare providers, particularly larger institutions, can negotiate better prices and terms with stent manufacturers. However, patient demand for effective and advanced treatment options gives stent manufacturers leverage in terms of pricing, especially for high-quality or innovative products.

What is the threat of substitute products in the coronary stents market in 2025?

The threat of substitutes is moderate. While coronary bypass surgery and pharmaceutical therapies (such as antiplatelet drugs) can serve as alternatives to stent implantation, they are generally more invasive or less effective for certain patient groups. However, the rise of alternative medical devices or treatments may increase the competition in the future.

What is the intensity of competitive rivalry in the coronary stents market in 2025?

The intensity of competitive rivalry is high. The market is dominated by a few major players who continuously innovate to maintain a competitive edge. However, the emergence of new technologies and the pressure to lower costs while maintaining product quality heighten competition among established manufacturers.

What are the key raw materials required for the coronary stents market in 2025?

Key raw materials include biocompatible metals such as stainless steel, cobalt-chromium, and titanium, as well as polymers for coating drug-eluting stents. Additionally, bioresorbable materials and advanced drug coatings are essential for the production of innovative stents. These materials are crucial for ensuring safety, performance, and longevity of the stents.

Who are the major suppliers in the upstream value chain for coronary stents in 2025?

Major suppliers in the upstream value chain include manufacturers of medical-grade metals, polymer suppliers, and companies that specialize in drug delivery systems. Additionally, specialized manufacturers of coating materials and suppliers of advanced technologies for stent production, such as bioresorbable components and drug-eluting substances, are also important contributors.

What role does research and development play in the upstream activities of the coronary stents market in 2025?

R&D plays a critical role in the upstream activities of the coronary stents market, as it drives innovation in stent materials, drug coatings, and bioresorbable technologies. Investment in R&D allows suppliers to develop safer, more effective products that meet the regulatory requirements, as well as cater to evolving patient needs and improve stent performance.

How does regulation impact the upstream activities in the coronary stents market in 2025?

Regulation significantly impacts upstream activities by ensuring that raw materials and components used in stents meet stringent safety, quality, and performance standards. Regulatory bodies, such as the FDA and EMA, enforce rigorous testing and approval processes for new materials and devices, which can affect the production timelines and cost structures of suppliers.

What challenges do upstream suppliers face in the coronary stents market in 2025?

Upstream suppliers face challenges such as the high cost of R&D, stringent regulatory requirements, and the need for continuous innovation to meet market demands for safer, more effective stent technologies. Supply chain disruptions, particularly for specialized raw materials, and increasing pressure to reduce costs while maintaining high-quality standards, are also significant challenges.

What are the key activities in the midstream phase of the coronary stents market in 2025?

Key activities in the midstream phase include the assembly and manufacturing of coronary stents, including drug-eluting and bioresorbable stents. It also involves quality control, testing, packaging, and distribution to hospitals and healthcare providers. This phase ensures that the stents meet regulatory standards and are ready for use in medical procedures.

Who are the key players in the midstream phase of the coronary stents market in 2025?

The key players in the midstream phase include stent manufacturers such as Medtronic, Abbott, Boston Scientific, and Johnson & Johnson, who specialize in the production and commercialization of stents. Additionally, contract manufacturers and third-party distributors play a significant role in the assembly and supply chain of coronary stents.

How does technology impact the midstream activities in the coronary stents market in 2025?

Technology plays a significant role in improving the precision and quality of stent manufacturing. Advanced manufacturing technologies like laser cutting and 3D printing are used for precision engineering of stents. Moreover, automation in the assembly and packaging process helps increase production efficiency and ensures consistency in product quality.

What are the regulatory considerations for midstream activities in the coronary stents market in 2025?

Regulatory considerations are critical in the midstream phase, as stents must comply with strict medical device regulations set by bodies such as the FDA and EMA. Manufacturers need to ensure that all products undergo rigorous testing for safety and efficacy before reaching the market. Compliance with these regulations is necessary for obtaining approvals and avoiding product recalls or legal issues.

What challenges are faced in the midstream phase of the coronary stents market in 2025?

Challenges in the midstream phase include the increasing cost of production, especially with the demand for higher quality and more advanced stent technologies like drug-eluting and bioresorbable stents. Supply chain disruptions and ensuring consistent quality control amid high production volumes are other challenges. Additionally, adapting to evolving regulatory requirements can also create obstacles for manufacturers.

What are the key activities in the downstream phase of the coronary stents market in 2025?

Key activities in the downstream phase include the distribution, sales, and clinical use of coronary stents. Hospitals, clinics, and healthcare providers perform the implantation procedures, while post-implantation care and patient monitoring also form a critical part of the downstream process. Additionally, healthcare providers ensure proper reimbursement processes and patient follow-ups.

Who are the primary customers in the downstream phase of the coronary stents market in 2025?

The primary customers are hospitals, cardiac clinics, interventional cardiologists, and healthcare providers who directly purchase and use stents for patients suffering from coronary artery diseases. Additionally, patients undergoing coronary interventions, especially those with advanced cardiovascular conditions, are the end users of the products.

How does reimbursement influence the downstream activities in the coronary stents market in 2025?

Reimbursement plays a crucial role in the downstream phase, as it determines the affordability and accessibility of coronary stents for patients. Insurance policies, government healthcare programs, and hospital budgets influence the availability of stents and impact the decision-making process of healthcare providers. Variations in reimbursement rates across regions can create disparities in market access.

What role does patient education play in the downstream phase of the coronary stents market in 2025?

Patient education is essential in the downstream phase, as informed patients are more likely to adhere to treatment plans and follow post-implantation care. Education about the benefits and risks of coronary stents, as well as lifestyle changes, can improve outcomes and reduce the likelihood of complications, ensuring the success of stent implantation procedures.

What challenges are faced in the downstream phase of the coronary stents market in 2025?

Challenges include variations in healthcare infrastructure and access, particularly in developing regions, leading to unequal adoption of coronary stents. Additionally, reimbursement complexities, healthcare cost pressures, and the need for continuous physician training on advanced stent technologies can affect market penetration. Moreover, patient compliance with follow-up care and post-implantation treatment remains a significant hurdle.

Chapter 1, to describe Coronary Stents product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Coronary Stents, with price, sales, revenue and global market share of Coronary Stents from 2018 to 2023.
Chapter 3, the Coronary Stents competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Coronary Stents breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Coronary Stents market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Coronary Stents.
Chapter 14 and 15, to describe Coronary Stents sales channel, distributors, customers, research findings and conclusion.

1 Market Overview

   1.1 Product Overview and Scope of Coronary Stents
   1.2 Market Estimation Caveats and Base Year
   1.3 Market Analysis by Type
       1.3.1 Overview: Global Coronary Stents Consumption Value by Type: 2018 Versus 2022 Versus 2029
       1.3.2 Bare-metal Stent (BMS)
       1.3.3 Drug-eluting Stent (DES)
       1.3.4 Bioresorbable Vascular Scaffold (BVS)
   1.4 Market Analysis by Application
       1.4.1 Overview: Global Coronary Stents Consumption Value by Application: 2018 Versus 2022 Versus 2029
       1.4.2 ASCs
       1.4.3 Hospitals
       1.4.4 Cardiology Center
   1.5 Global Coronary Stents Market Size & Forecast
       1.5.1 Global Coronary Stents Consumption Value (2018 & 2022 & 2029)
       1.5.2 Global Coronary Stents Sales Quantity (2018-2029)
       1.5.3 Global Coronary Stents Average Price (2018-2029)

2 Manufacturers Profiles

   2.1 Medtronic
       2.1.1 Medtronic Details
       2.1.2 Medtronic Major Business
       2.1.3 Medtronic Coronary Stents Product and Services
       2.1.4 Medtronic Coronary Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.1.5 Medtronic Recent Developments/Updates
   2.2 Boston Scientific
       2.2.1 Boston Scientific Details
       2.2.2 Boston Scientific Major Business
       2.2.3 Boston Scientific Coronary Stents Product and Services
       2.2.4 Boston Scientific Coronary Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.2.5 Boston Scientific Recent Developments/Updates
   2.3 Biosensors
       2.3.1 Biosensors Details
       2.3.2 Biosensors Major Business
       2.3.3 Biosensors Coronary Stents Product and Services
       2.3.4 Biosensors Coronary Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.3.5 Biosensors Recent Developments/Updates
   2.4 Terumo
       2.4.1 Terumo Details
       2.4.2 Terumo Major Business
       2.4.3 Terumo Coronary Stents Product and Services
       2.4.4 Terumo Coronary Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.4.5 Terumo Recent Developments/Updates
   2.5 MicroPort
       2.5.1 MicroPort Details
       2.5.2 MicroPort Major Business
       2.5.3 MicroPort Coronary Stents Product and Services
       2.5.4 MicroPort Coronary Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.5.5 MicroPort Recent Developments/Updates
   2.6 Lepu Medical
       2.6.1 Lepu Medical Details
       2.6.2 Lepu Medical Major Business
       2.6.3 Lepu Medical Coronary Stents Product and Services
       2.6.4 Lepu Medical Coronary Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.6.5 Lepu Medical Recent Developments/Updates
   2.7 B.Braun
       2.7.1 B.Braun Details
       2.7.2 B.Braun Major Business
       2.7.3 B.Braun Coronary Stents Product and Services
       2.7.4 B.Braun Coronary Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.7.5 B.Braun Recent Developments/Updates
   2.8 Atrium Medical
       2.8.1 Atrium Medical Details
       2.8.2 Atrium Medical Major Business
       2.8.3 Atrium Medical Coronary Stents Product and Services
       2.8.4 Atrium Medical Coronary Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.8.5 Atrium Medical Recent Developments/Updates
   2.9 SINOMED
       2.9.1 SINOMED Details
       2.9.2 SINOMED Major Business
       2.9.3 SINOMED Coronary Stents Product and Services
       2.9.4 SINOMED Coronary Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.9.5 SINOMED Recent Developments/Updates
   2.10 LBC
       2.10.1 LBC Details
       2.10.2 LBC Major Business
       2.10.3 LBC Coronary Stents Product and Services
       2.10.4 LBC Coronary Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.10.5 LBC Recent Developments/Updates
   2.11 Essen Technology
       2.11.1 Essen Technology Details
       2.11.2 Essen Technology Major Business
       2.11.3 Essen Technology Coronary Stents Product and Services
       2.11.4 Essen Technology Coronary Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.11.5 Essen Technology Recent Developments/Updates

3 Competitive Environment: Coronary Stents by Manufacturer

   3.1 Global Coronary Stents Sales Quantity by Manufacturer (2018-2023)
   3.2 Global Coronary Stents Revenue by Manufacturer (2018-2023)
   3.3 Global Coronary Stents Average Price by Manufacturer (2018-2023)
   3.4 Market Share Analysis (2022)
       3.4.1 Producer Shipments of Coronary Stents by Manufacturer Revenue ($MM) and Market Share (%): 2022
       3.4.2 Top 3 Coronary Stents Manufacturer Market Share in 2022
       3.4.2 Top 6 Coronary Stents Manufacturer Market Share in 2022
   3.5 Coronary Stents Market: Overall Company Footprint Analysis
       3.5.1 Coronary Stents Market: Region Footprint
       3.5.2 Coronary Stents Market: Company Product Type Footprint
       3.5.3 Coronary Stents Market: Company Product Application Footprint
   3.6 New Market Entrants and Barriers to Market Entry
   3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

   4.1 Global Coronary Stents Market Size by Region
       4.1.1 Global Coronary Stents Sales Quantity by Region (2018-2029)
       4.1.2 Global Coronary Stents Consumption Value by Region (2018-2029)
       4.1.3 Global Coronary Stents Average Price by Region (2018-2029)
   4.2 North America Coronary Stents Consumption Value (2018-2029)
   4.3 Europe Coronary Stents Consumption Value (2018-2029)
   4.4 Asia-Pacific Coronary Stents Consumption Value (2018-2029)
   4.5 South America Coronary Stents Consumption Value (2018-2029)
   4.6 Middle East and Africa Coronary Stents Consumption Value (2018-2029)

5 Market Segment by Type

   5.1 Global Coronary Stents Sales Quantity by Type (2018-2029)
   5.2 Global Coronary Stents Consumption Value by Type (2018-2029)
   5.3 Global Coronary Stents Average Price by Type (2018-2029)

6 Market Segment by Application

   6.1 Global Coronary Stents Sales Quantity by Application (2018-2029)
   6.2 Global Coronary Stents Consumption Value by Application (2018-2029)
   6.3 Global Coronary Stents Average Price by Application (2018-2029)

7 North America

   7.1 North America Coronary Stents Sales Quantity by Type (2018-2029)
   7.2 North America Coronary Stents Sales Quantity by Application (2018-2029)
   7.3 North America Coronary Stents Market Size by Country
       7.3.1 North America Coronary Stents Sales Quantity by Country (2018-2029)
       7.3.2 North America Coronary Stents Consumption Value by Country (2018-2029)
       7.3.3 United States Market Size and Forecast (2018-2029)
       7.3.4 Canada Market Size and Forecast (2018-2029)
       7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

   8.1 Europe Coronary Stents Sales Quantity by Type (2018-2029)
   8.2 Europe Coronary Stents Sales Quantity by Application (2018-2029)
   8.3 Europe Coronary Stents Market Size by Country
       8.3.1 Europe Coronary Stents Sales Quantity by Country (2018-2029)
       8.3.2 Europe Coronary Stents Consumption Value by Country (2018-2029)
       8.3.3 Germany Market Size and Forecast (2018-2029)
       8.3.4 France Market Size and Forecast (2018-2029)
       8.3.5 United Kingdom Market Size and Forecast (2018-2029)
       8.3.6 Russia Market Size and Forecast (2018-2029)
       8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

   9.1 Asia-Pacific Coronary Stents Sales Quantity by Type (2018-2029)
   9.2 Asia-Pacific Coronary Stents Sales Quantity by Application (2018-2029)
   9.3 Asia-Pacific Coronary Stents Market Size by Region
       9.3.1 Asia-Pacific Coronary Stents Sales Quantity by Region (2018-2029)
       9.3.2 Asia-Pacific Coronary Stents Consumption Value by Region (2018-2029)
       9.3.3 China Market Size and Forecast (2018-2029)
       9.3.4 Japan Market Size and Forecast (2018-2029)
       9.3.5 Korea Market Size and Forecast (2018-2029)
       9.3.6 India Market Size and Forecast (2018-2029)
       9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
       9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

   10.1 South America Coronary Stents Sales Quantity by Type (2018-2029)
   10.2 South America Coronary Stents Sales Quantity by Application (2018-2029)
   10.3 South America Coronary Stents Market Size by Country
       10.3.1 South America Coronary Stents Sales Quantity by Country (2018-2029)
       10.3.2 South America Coronary Stents Consumption Value by Country (2018-2029)
       10.3.3 Brazil Market Size and Forecast (2018-2029)
       10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

   11.1 Middle East & Africa Coronary Stents Sales Quantity by Type (2018-2029)
   11.2 Middle East & Africa Coronary Stents Sales Quantity by Application (2018-2029)
   11.3 Middle East & Africa Coronary Stents Market Size by Country
       11.3.1 Middle East & Africa Coronary Stents Sales Quantity by Country (2018-2029)
       11.3.2 Middle East & Africa Coronary Stents Consumption Value by Country (2018-2029)
       11.3.3 Turkey Market Size and Forecast (2018-2029)
       11.3.4 Egypt Market Size and Forecast (2018-2029)
       11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
       11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

   12.1 Coronary Stents Market Drivers
   12.2 Coronary Stents Market Restraints
   12.3 Coronary Stents Trends Analysis
   12.4 Porters Five Forces Analysis
       12.4.1 Threat of New Entrants
       12.4.2 Bargaining Power of Suppliers
       12.4.3 Bargaining Power of Buyers
       12.4.4 Threat of Substitutes
       12.4.5 Competitive Rivalry
   12.5 Influence of COVID-19 and Russia-Ukraine War
       12.5.1 Influence of COVID-19
       12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

   13.1 Raw Material of Coronary Stents and Key Manufacturers
   13.2 Manufacturing Costs Percentage of Coronary Stents
   13.3 Coronary Stents Production Process
   13.4 Coronary Stents Industrial Chain

14 Shipments by Distribution Channel

   14.1 Sales Channel
       14.1.1 Direct to End-User
       14.1.2 Distributors
   14.2 Coronary Stents Typical Distributors
   14.3 Coronary Stents Typical Customers

15 Research Findings and Conclusion

16 Appendix

   16.1 Methodology
   16.2 Research Process and Data Source
   16.3 Disclaimer

List of Tables

   Table 1. Global Coronary Stents Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Table 2. Global Coronary Stents Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Table 3. Medtronic Basic Information, Manufacturing Base and Competitors
   Table 4. Medtronic Major Business
   Table 5. Medtronic Coronary Stents Product and Services
   Table 6. Medtronic Coronary Stents Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 7. Medtronic Recent Developments/Updates
   Table 8. Boston Scientific Basic Information, Manufacturing Base and Competitors
   Table 9. Boston Scientific Major Business
   Table 10. Boston Scientific Coronary Stents Product and Services
   Table 11. Boston Scientific Coronary Stents Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 12. Boston Scientific Recent Developments/Updates
   Table 13. Biosensors Basic Information, Manufacturing Base and Competitors
   Table 14. Biosensors Major Business
   Table 15. Biosensors Coronary Stents Product and Services
   Table 16. Biosensors Coronary Stents Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 17. Biosensors Recent Developments/Updates
   Table 18. Terumo Basic Information, Manufacturing Base and Competitors
   Table 19. Terumo Major Business
   Table 20. Terumo Coronary Stents Product and Services
   Table 21. Terumo Coronary Stents Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 22. Terumo Recent Developments/Updates
   Table 23. MicroPort Basic Information, Manufacturing Base and Competitors
   Table 24. MicroPort Major Business
   Table 25. MicroPort Coronary Stents Product and Services
   Table 26. MicroPort Coronary Stents Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 27. MicroPort Recent Developments/Updates
   Table 28. Lepu Medical Basic Information, Manufacturing Base and Competitors
   Table 29. Lepu Medical Major Business
   Table 30. Lepu Medical Coronary Stents Product and Services
   Table 31. Lepu Medical Coronary Stents Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 32. Lepu Medical Recent Developments/Updates
   Table 33. B.Braun Basic Information, Manufacturing Base and Competitors
   Table 34. B.Braun Major Business
   Table 35. B.Braun Coronary Stents Product and Services
   Table 36. B.Braun Coronary Stents Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 37. B.Braun Recent Developments/Updates
   Table 38. Atrium Medical Basic Information, Manufacturing Base and Competitors
   Table 39. Atrium Medical Major Business
   Table 40. Atrium Medical Coronary Stents Product and Services
   Table 41. Atrium Medical Coronary Stents Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 42. Atrium Medical Recent Developments/Updates
   Table 43. SINOMED Basic Information, Manufacturing Base and Competitors
   Table 44. SINOMED Major Business
   Table 45. SINOMED Coronary Stents Product and Services
   Table 46. SINOMED Coronary Stents Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 47. SINOMED Recent Developments/Updates
   Table 48. LBC Basic Information, Manufacturing Base and Competitors
   Table 49. LBC Major Business
   Table 50. LBC Coronary Stents Product and Services
   Table 51. LBC Coronary Stents Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 52. LBC Recent Developments/Updates
   Table 53. Essen Technology Basic Information, Manufacturing Base and Competitors
   Table 54. Essen Technology Major Business
   Table 55. Essen Technology Coronary Stents Product and Services
   Table 56. Essen Technology Coronary Stents Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 57. Essen Technology Recent Developments/Updates
   Table 58. Global Coronary Stents Sales Quantity by Manufacturer (2018-2023) & (K Units)
   Table 59. Global Coronary Stents Revenue by Manufacturer (2018-2023) & (USD Million)
   Table 60. Global Coronary Stents Average Price by Manufacturer (2018-2023) & (USD/Unit)
   Table 61. Market Position of Manufacturers in Coronary Stents, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
   Table 62. Head Office and Coronary Stents Production Site of Key Manufacturer
   Table 63. Coronary Stents Market: Company Product Type Footprint
   Table 64. Coronary Stents Market: Company Product Application Footprint
   Table 65. Coronary Stents New Market Entrants and Barriers to Market Entry
   Table 66. Coronary Stents Mergers, Acquisition, Agreements, and Collaborations
   Table 67. Global Coronary Stents Sales Quantity by Region (2018-2023) & (K Units)
   Table 68. Global Coronary Stents Sales Quantity by Region (2024-2029) & (K Units)
   Table 69. Global Coronary Stents Consumption Value by Region (2018-2023) & (USD Million)
   Table 70. Global Coronary Stents Consumption Value by Region (2024-2029) & (USD Million)
   Table 71. Global Coronary Stents Average Price by Region (2018-2023) & (USD/Unit)
   Table 72. Global Coronary Stents Average Price by Region (2024-2029) & (USD/Unit)
   Table 73. Global Coronary Stents Sales Quantity by Type (2018-2023) & (K Units)
   Table 74. Global Coronary Stents Sales Quantity by Type (2024-2029) & (K Units)
   Table 75. Global Coronary Stents Consumption Value by Type (2018-2023) & (USD Million)
   Table 76. Global Coronary Stents Consumption Value by Type (2024-2029) & (USD Million)
   Table 77. Global Coronary Stents Average Price by Type (2018-2023) & (USD/Unit)
   Table 78. Global Coronary Stents Average Price by Type (2024-2029) & (USD/Unit)
   Table 79. Global Coronary Stents Sales Quantity by Application (2018-2023) & (K Units)
   Table 80. Global Coronary Stents Sales Quantity by Application (2024-2029) & (K Units)
   Table 81. Global Coronary Stents Consumption Value by Application (2018-2023) & (USD Million)
   Table 82. Global Coronary Stents Consumption Value by Application (2024-2029) & (USD Million)
   Table 83. Global Coronary Stents Average Price by Application (2018-2023) & (USD/Unit)
   Table 84. Global Coronary Stents Average Price by Application (2024-2029) & (USD/Unit)
   Table 85. North America Coronary Stents Sales Quantity by Type (2018-2023) & (K Units)
   Table 86. North America Coronary Stents Sales Quantity by Type (2024-2029) & (K Units)
   Table 87. North America Coronary Stents Sales Quantity by Application (2018-2023) & (K Units)
   Table 88. North America Coronary Stents Sales Quantity by Application (2024-2029) & (K Units)
   Table 89. North America Coronary Stents Sales Quantity by Country (2018-2023) & (K Units)
   Table 90. North America Coronary Stents Sales Quantity by Country (2024-2029) & (K Units)
   Table 91. North America Coronary Stents Consumption Value by Country (2018-2023) & (USD Million)
   Table 92. North America Coronary Stents Consumption Value by Country (2024-2029) & (USD Million)
   Table 93. Europe Coronary Stents Sales Quantity by Type (2018-2023) & (K Units)
   Table 94. Europe Coronary Stents Sales Quantity by Type (2024-2029) & (K Units)
   Table 95. Europe Coronary Stents Sales Quantity by Application (2018-2023) & (K Units)
   Table 96. Europe Coronary Stents Sales Quantity by Application (2024-2029) & (K Units)
   Table 97. Europe Coronary Stents Sales Quantity by Country (2018-2023) & (K Units)
   Table 98. Europe Coronary Stents Sales Quantity by Country (2024-2029) & (K Units)
   Table 99. Europe Coronary Stents Consumption Value by Country (2018-2023) & (USD Million)
   Table 100. Europe Coronary Stents Consumption Value by Country (2024-2029) & (USD Million)
   Table 101. Asia-Pacific Coronary Stents Sales Quantity by Type (2018-2023) & (K Units)
   Table 102. Asia-Pacific Coronary Stents Sales Quantity by Type (2024-2029) & (K Units)
   Table 103. Asia-Pacific Coronary Stents Sales Quantity by Application (2018-2023) & (K Units)
   Table 104. Asia-Pacific Coronary Stents Sales Quantity by Application (2024-2029) & (K Units)
   Table 105. Asia-Pacific Coronary Stents Sales Quantity by Region (2018-2023) & (K Units)
   Table 106. Asia-Pacific Coronary Stents Sales Quantity by Region (2024-2029) & (K Units)
   Table 107. Asia-Pacific Coronary Stents Consumption Value by Region (2018-2023) & (USD Million)
   Table 108. Asia-Pacific Coronary Stents Consumption Value by Region (2024-2029) & (USD Million)
   Table 109. South America Coronary Stents Sales Quantity by Type (2018-2023) & (K Units)
   Table 110. South America Coronary Stents Sales Quantity by Type (2024-2029) & (K Units)
   Table 111. South America Coronary Stents Sales Quantity by Application (2018-2023) & (K Units)
   Table 112. South America Coronary Stents Sales Quantity by Application (2024-2029) & (K Units)
   Table 113. South America Coronary Stents Sales Quantity by Country (2018-2023) & (K Units)
   Table 114. South America Coronary Stents Sales Quantity by Country (2024-2029) & (K Units)
   Table 115. South America Coronary Stents Consumption Value by Country (2018-2023) & (USD Million)
   Table 116. South America Coronary Stents Consumption Value by Country (2024-2029) & (USD Million)
   Table 117. Middle East & Africa Coronary Stents Sales Quantity by Type (2018-2023) & (K Units)
   Table 118. Middle East & Africa Coronary Stents Sales Quantity by Type (2024-2029) & (K Units)
   Table 119. Middle East & Africa Coronary Stents Sales Quantity by Application (2018-2023) & (K Units)
   Table 120. Middle East & Africa Coronary Stents Sales Quantity by Application (2024-2029) & (K Units)
   Table 121. Middle East & Africa Coronary Stents Sales Quantity by Region (2018-2023) & (K Units)
   Table 122. Middle East & Africa Coronary Stents Sales Quantity by Region (2024-2029) & (K Units)
   Table 123. Middle East & Africa Coronary Stents Consumption Value by Region (2018-2023) & (USD Million)
   Table 124. Middle East & Africa Coronary Stents Consumption Value by Region (2024-2029) & (USD Million)
   Table 125. Coronary Stents Raw Material
   Table 126. Key Manufacturers of Coronary Stents Raw Materials
   Table 127. Coronary Stents Typical Distributors
   Table 128. Coronary Stents Typical Customers

List of Figures

   Figure 1. Coronary Stents Picture
   Figure 2. Global Coronary Stents Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 3. Global Coronary Stents Consumption Value Market Share by Type in 2022
   Figure 4. Bare-metal Stent (BMS) Examples
   Figure 5. Drug-eluting Stent (DES) Examples
   Figure 6. Bioresorbable Vascular Scaffold (BVS) Examples
   Figure 7. Global Coronary Stents Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Figure 8. Global Coronary Stents Consumption Value Market Share by Application in 2022
   Figure 9. ASCs Examples
   Figure 10. Hospitals Examples
   Figure 11. Cardiology Center Examples
   Figure 12. Global Coronary Stents Consumption Value, (USD Million): 2018 & 2022 & 2029
   Figure 13. Global Coronary Stents Consumption Value and Forecast (2018-2029) & (USD Million)
   Figure 14. Global Coronary Stents Sales Quantity (2018-2029) & (K Units)
   Figure 15. Global Coronary Stents Average Price (2018-2029) & (USD/Unit)
   Figure 16. Global Coronary Stents Sales Quantity Market Share by Manufacturer in 2022
   Figure 17. Global Coronary Stents Consumption Value Market Share by Manufacturer in 2022
   Figure 18. Producer Shipments of Coronary Stents by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
   Figure 19. Top 3 Coronary Stents Manufacturer (Consumption Value) Market Share in 2022
   Figure 20. Top 6 Coronary Stents Manufacturer (Consumption Value) Market Share in 2022
   Figure 21. Global Coronary Stents Sales Quantity Market Share by Region (2018-2029)
   Figure 22. Global Coronary Stents Consumption Value Market Share by Region (2018-2029)
   Figure 23. North America Coronary Stents Consumption Value (2018-2029) & (USD Million)
   Figure 24. Europe Coronary Stents Consumption Value (2018-2029) & (USD Million)
   Figure 25. Asia-Pacific Coronary Stents Consumption Value (2018-2029) & (USD Million)
   Figure 26. South America Coronary Stents Consumption Value (2018-2029) & (USD Million)
   Figure 27. Middle East & Africa Coronary Stents Consumption Value (2018-2029) & (USD Million)
   Figure 28. Global Coronary Stents Sales Quantity Market Share by Type (2018-2029)
   Figure 29. Global Coronary Stents Consumption Value Market Share by Type (2018-2029)
   Figure 30. Global Coronary Stents Average Price by Type (2018-2029) & (USD/Unit)
   Figure 31. Global Coronary Stents Sales Quantity Market Share by Application (2018-2029)
   Figure 32. Global Coronary Stents Consumption Value Market Share by Application (2018-2029)
   Figure 33. Global Coronary Stents Average Price by Application (2018-2029) & (USD/Unit)
   Figure 34. North America Coronary Stents Sales Quantity Market Share by Type (2018-2029)
   Figure 35. North America Coronary Stents Sales Quantity Market Share by Application (2018-2029)
   Figure 36. North America Coronary Stents Sales Quantity Market Share by Country (2018-2029)
   Figure 37. North America Coronary Stents Consumption Value Market Share by Country (2018-2029)
   Figure 38. United States Coronary Stents Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 39. Canada Coronary Stents Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 40. Mexico Coronary Stents Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 41. Europe Coronary Stents Sales Quantity Market Share by Type (2018-2029)
   Figure 42. Europe Coronary Stents Sales Quantity Market Share by Application (2018-2029)
   Figure 43. Europe Coronary Stents Sales Quantity Market Share by Country (2018-2029)
   Figure 44. Europe Coronary Stents Consumption Value Market Share by Country (2018-2029)
   Figure 45. Germany Coronary Stents Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 46. France Coronary Stents Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 47. United Kingdom Coronary Stents Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 48. Russia Coronary Stents Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 49. Italy Coronary Stents Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 50. Asia-Pacific Coronary Stents Sales Quantity Market Share by Type (2018-2029)
   Figure 51. Asia-Pacific Coronary Stents Sales Quantity Market Share by Application (2018-2029)
   Figure 52. Asia-Pacific Coronary Stents Sales Quantity Market Share by Region (2018-2029)
   Figure 53. Asia-Pacific Coronary Stents Consumption Value Market Share by Region (2018-2029)
   Figure 54. China Coronary Stents Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 55. Japan Coronary Stents Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 56. Korea Coronary Stents Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 57. India Coronary Stents Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 58. Southeast Asia Coronary Stents Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 59. Australia Coronary Stents Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 60. South America Coronary Stents Sales Quantity Market Share by Type (2018-2029)
   Figure 61. South America Coronary Stents Sales Quantity Market Share by Application (2018-2029)
   Figure 62. South America Coronary Stents Sales Quantity Market Share by Country (2018-2029)
   Figure 63. South America Coronary Stents Consumption Value Market Share by Country (2018-2029)
   Figure 64. Brazil Coronary Stents Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 65. Argentina Coronary Stents Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 66. Middle East & Africa Coronary Stents Sales Quantity Market Share by Type (2018-2029)
   Figure 67. Middle East & Africa Coronary Stents Sales Quantity Market Share by Application (2018-2029)
   Figure 68. Middle East & Africa Coronary Stents Sales Quantity Market Share by Region (2018-2029)
   Figure 69. Middle East & Africa Coronary Stents Consumption Value Market Share by Region (2018-2029)
   Figure 70. Turkey Coronary Stents Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 71. Egypt Coronary Stents Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 72. Saudi Arabia Coronary Stents Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 73. South Africa Coronary Stents Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 74. Coronary Stents Market Drivers
   Figure 75. Coronary Stents Market Restraints
   Figure 76. Coronary Stents Market Trends
   Figure 77. Porters Five Forces Analysis
   Figure 78. Manufacturing Cost Structure Analysis of Coronary Stents in 2022
   Figure 79. Manufacturing Process Analysis of Coronary Stents
   Figure 80. Coronary Stents Industrial Chain
   Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
   Figure 82. Direct Channel Pros & Cons
   Figure 83. Indirect Channel Pros & Cons
   Figure 84. Methodology
   Figure 85. Research Process and Data Source